EnBiotix, Inc. Closes $11M Pre-Merger Financing
December 29, 2021 02:30 ET
|
EnBiotix, Inc.
BOSTON, Dec. 29, 2021 (GLOBE NEWSWIRE) -- EnBiotix, Inc., a rare disease company currently focused on chronic respiratory disorders, today announced the closing of an $11M pre-merger, convertible...
Adamis Pharmaceuticals Regains Compliance with NASDAQ Continued Listing Requirements
November 23, 2021 14:39 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid...
Adamis Pharmaceuticals Announces Third Quarter 2021 Financial Results and Provides Corporate Update
November 22, 2021 16:47 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid...
Adamis Pharmaceuticals Schedules Financial Results Conference Call and Business Update
November 19, 2021 15:34 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for allergy, opioid...
Adamis Announces Appointment of Meera Desai, Ph.D., to Board of Directors
October 04, 2021 07:30 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today announced the appointment of Meera J. Desai, Ph.D., as a new director and member of the company’s...
Global Respiratory Disease Testing Market to Grow at a CAGR of 9.2% and Garner a Revenue of $20.1 Billion during the Forecast Period from 2020 to 2027 – Exclusive Report [227 Pages] By Research Dive
September 27, 2021 09:00 ET
|
Research Dive
New York, USA, Sept. 27, 2021 (GLOBE NEWSWIRE) -- A research report published by Research dive on the global respiratory disease testing market explains the impact of COVID-19 pandemic on the...
Global Obstructive Lung Disease Management Markets 2021: Opportunities Led by Big Pharma and Medical Device Companies and New Collaborations in Developing Affordable and Quality-Driven Treatments
September 23, 2021 04:58 ET
|
Research and Markets
Dublin, Sept. 23, 2021 (GLOBE NEWSWIRE) -- The "Global Obstructive Lung Disease Management Market Report 2021" report has been added to ResearchAndMarkets.com's offering. The report provides a...
Adamis Announces Appointment of David C. Benedicto as Chief Financial Officer and Other Events
August 24, 2021 16:05 ET
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that David C. Benedicto, who has been serving as the Company’s Chief Accounting...
Global Respiratory Care Medical Devices Market Report 2021-2025: Increasing Demand for Enhanced Portable Devices & Focus of Market Players to Expand Geographic Presence
April 28, 2021 07:33 ET
|
Research and Markets
Dublin, April 28, 2021 (GLOBE NEWSWIRE) -- The "Global Respiratory Care Medical Devices Market: Size, Trends & Forecasts (2021-2025 Edition)" report has been added to ResearchAndMarkets.com's...
COPD and Asthma Devices Market is anticipated to hit $51.62 billion by 2027, At CAGR 4.3%
November 04, 2020 10:00 ET
|
Allied Market Research
Portland, OR, Nov. 04, 2020 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research the global COPD and asthma devices market size was estimated at $36.45 billion in 2019,...